IP Verse

A Diphenylsulfonamide Endothelin And Angiotensin Ii Receptor Antagonists To Treatglomerulosclerosis

Patent No. EP3222277 (titled "A Diphenylsulfonamide Endothelin And Angiotensin Ii Receptor Antagonists To Treatglomerulosclerosis") was filed by Ligand Pharmaceuticals on Mar 29, 2010. The application was issued on Feb 26, 2020.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
PAJARONov 23, 2020HOPFNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP3222277

LIGAND PHARMACEUTICALS
Application Number
EP17157697A
Filing Date
Mar 29, 2010
Status
Revoked
May 14, 2026
Publication Date
Feb 26, 2020
External Links
Slate, Register , Google Patents